Physician profile
Robert Joseph Maxwell
NPI 1396722443
$327.77
in general payments reported to CMS, 2019-2025
7 companies · $63.28 in 2025
The $63.28 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.38 · 2020: $40.47 · 2021: $21.90 · 2023: $148 · 2024: $39.73 · 2025: $63.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merit Medical Systems INC | $118.95 | 2023 | Savi Scout |
| Ethicon US, LLC | $76.16 | 2020-2024 | Surgiflo Hemostatic Matrix, Ethicon, Dermabond |
| Davol INC. | $36.37 | 2025 | Arista |
| Merck Sharp & Dohme LLC | $27.28 | 2019-2020 | |
| Smith+Nephew, INC. | $26.91 | 2025 | Collagenase Santyl |
| Baxter Healthcare | $21.90 | 2021 | |
| Solventum Corporation | $20.20 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C. Dermatac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Maxwell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.